IL6 and type 2 diabetes mellitus: PZA and INH treatment to in vitro granulomas generated from T2DM subjects at 3-months post- L-GSH supplementation also resulted in a significant decrease in the production of IL-6 when compared to before L-GSH supplementation in the untreated (control) category (Figure 7A).